Clinical Trial Update: CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Longitudinal Study

View source ↗

Summary

A completed longitudinal study evaluating continuous subcutaneous insulin infusion (CSII) in people with Type 1 diabetes, focusing on diet, quality of life, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Liverpool John Moores University | Conditions: Type 1 Diabetes | Status: COMPLETED